UPDATE: BMO Downgrades Bristol-Myers Squibb
May 15, 2014 at 10:37 AM EDT
BMO downgraded Bristol-Myers Squibb (NYSE: BMY) from Outperform to a Market Perform rating. Alex Arfaei said, "We were wrong to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.